Barrington Research lifted their price target on shares of Cinemark Holdings (NYSE: CNK) from $28.00 to $30.00 in a research note issued on Friday. The firm currently has an “outperform” rating on the stock.
Several other analysts have also recently commented on the stock. Analysts at Barclays Capital (NYSE: BCS) raised their price target on shares of Cinemark Holdings from $24.00 to $26.00 in a research note to investors on Tuesday, May 8th. They now have an “equal weight” rating on the stock. Separately, analysts at Hudson Square Research raised their price target on shares of Cinemark Holdings from $25.00 to $28.00 in a research note to investors on Tuesday, May 8th. Finally, analysts at Nomura (NYSE: NMR) reiterated a “buy” rating on shares of Cinemark Holdings in a research note to investors on Monday, May 7th.
Shares of Cinemark Holdings opened at 24.12 on Friday. Cinemark Holdings has a 52 week low of $17.10 and a 52 week high of $23.26. The company has a market cap of $2.729 billion and a P/E ratio of 18.70.
Cinemark Holdings last announced its earnings results on Monday, May 7th. The company reported $0.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.34 by $0.03. The company’s quarterly revenue was up 19.8% on a year-over-year basis. Analysts expect that Cinemark Holdings will post $0.50 EPS next quarter.
Cinemark Holdings, Inc. (Cinemark) is a motion picture exhibitor, with theatres in the United States, Canada, Brazil, Mexico, Chile, Colombia, Argentina, Ecuador, Peru, Honduras, El Salvador, Nicaragua, Costa Rica, Panama and Guatemala.